Search Results 8311-8320 of 34182 for oral

  1. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  2. Shelley S. Noland, M.D. - Doctors and Medical Staff - Mayo Clinic

    2025. Oral Presentation selected as a Highlight of the Meeting (Hiredesai A, presenter) Annual Meeting Highlights Symposium, American Academy of Orthopaedic ...

  3. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  4. TUESDAY Q & A: Teen's hair loss likely result of genetics, but treatment options available

    ANSWER: In the vast majority of cases like your son's, the cause of hair loss is a condition called androgenic alopecia, or male-pattern baldness. It's usually ...

  5. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

    Treatment was 160 mg of oral zanubrutinib twice daily (n = 50) or 320 mg once daily (n = 23). Efficacy endpoints included overall response rate (ORR) and ...

  6. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Able to swallow and retain oral medications and without gastrointestinal (GI) illnesses that would preclude absorption of cediranib or olaparib; Women of ...

  7. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

    Cladribine, mitoxantrone, or oral cyclophosphamide at any time. Treatment with any investigational agent within 24 weeks or 5 drug-elimination half-lives of ...

  8. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

    Requires intermittent or chronic systemic (intravenous or oral) treatment with an antiherpetic drug (eg, acyclovir), other than intermittent topical use ...

  9. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

    Able to swallow oral medication. Both female and male patients of reproductive potential must agree to avoid pregnancy or impregnating a partner ...

  10. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...